Industry reports
Editor highlights

Cetuximab Comprehensive patent search

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Tissue Therapies Ltd

Tissue Therapies Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 40 pages

A textual analysis of the financial results for Tissue Therapies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biological Therapy

Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 42 pages

A textual analysis of the financial results for Zhongyuan Union Stem Cell Bio-Engineering Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security ...

Industries: Biological Therapy

Ecomic Co.,Ltd

Ecomic Co.,Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 41 pages

A textual analysis of the financial results for Ecomic Co.,Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biological Therapy | Countries: Japan

International Stem Cell Corporation

International Stem Cell Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 41 pages

A textual analysis of the financial results for International Stem Cell Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biological Therapy

Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 40 pages

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biological Therapy | Countries: Japan

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • March 2014

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 327 companies plus partners developing 426 Androgen Receptor drugs in 1397 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last years ...

Industries: Biological Therapy

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • March 2014

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 249 companies plus partners developing 343 Notch pathway targeting drugs in 1214 developmental projects in cancer. In addition, ...

Industries: Biological Therapy

Analytical Tool - Cancer Immunotherapy

Analytical Tool - Cancer Immunotherapy

  • $ 8 175
  • Industry report
  • by Bioseeker
  • March 2014

"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, ...

Industries: Biological Therapy

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • March 2014

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-receptor tyrosine kinases including those of the Src, Tec and Syk family of kinases. Downstream messengers ...

Industries: Biological Therapy

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • by Bioseeker
  • March 2014

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators in oncology drug development into one source. ...

Industries: Biological Therapy

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.